The pathophysiology of aldosterone in the cardiovascular system.
about
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasisPlasma sodium stiffens vascular endothelium and reduces nitric oxide release.Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists.Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis.Mineralocorticoid receptor antagonism prevents hedonic deficits induced by a chronic sodium appetite.Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation.Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thicknessEplerenone: the evidence for its place in the treatment of heart failure after myocardial infarctionSpironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone ratsProtective effects of angiotensin II interruption: evidence for antiinflammatory actions.Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methodsAntiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone SynthesisThe diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn RegistryA propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failureBlood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in childrenRole of mineralocorticoid action in the brain in salt-sensitive hypertension.Mineralocorticoid receptors in vascular function and disease.Emerging drugs which target the renin-angiotensin-aldosterone system.The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure.An emerging concept of vascular salt sensitivity.Diagnosis and management of primary aldosteronism: an updated review.Blood pressure control 1 year after referral to a hypertension specialist.Modulation of the renin-angiotensin-aldosterone system in heart failure.Hydration, fluid regulation and the eye: in health and disease.Treatment of Primary Aldosteronism and Organ Protection.Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis.High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells.Cardiac effects of anabolic steroids.Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels.Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism.Eplerenone.Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats.Impact of electrocardiographic findings for diagnosis of left ventricular hypertrophy in patients with primary aldosteronism.Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment.Is it time for spironolactone therapy in dialysis patients?Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension.
P2860
Q26995642-2FC76165-D3C7-48C5-B31E-0D8D56E2CCEAQ33301245-17C2EA91-7C6B-4834-AFFA-B68BB65C3391Q33580961-3E4DF4AB-F764-4124-AF0E-7E563E57DA0DQ33734806-FDFD53BD-72A0-4861-A1D1-EA1BA465081CQ34137311-6DEA1C6E-C39D-4E00-A468-6F8418E95637Q34600299-8DAF50C9-FB5D-4C83-96C8-3AAA928CBEFDQ34787751-5A5E8FE3-22E9-4D3F-B883-89F78080CC29Q35161719-9FABEE2F-B844-4CA2-BB50-9A70E1F4C76BQ35876377-759A592E-70FD-4710-BE01-04D7D2E45C70Q35878810-A300E33B-525D-47DE-89D6-06ABC5545466Q36257966-6076D040-3EA6-454F-9530-B51239115BF9Q36686822-67DF4D44-9721-4088-B96E-1566C81D8316Q36736504-A7917BC5-A87E-4277-B98B-ABBE38909CDEQ36743923-53DD801F-073D-45B0-AF4F-CF2909756AD9Q36944645-CEF88B21-6A03-44DA-9F29-9D5F3EAB534FQ37210382-ADF8E098-CC00-480A-960B-4626A24F7D07Q37255457-11C0BF36-19DA-44BC-B004-806A0196B8ABQ37304780-BF5379B8-2651-4096-A33A-FD6A9B8813C4Q37876462-3E30B300-B6A2-41C8-B2F0-986A0E80A24AQ37896953-19904CC0-2794-4692-AEE7-DE9C442FA2E5Q37929786-154A26B7-2D84-412C-9283-851983387369Q37945452-569A97DA-68D2-417A-971D-F256575513B6Q38056725-244DA1E8-A3F7-406E-932D-907C40990434Q38108818-49A571DB-B229-44D7-87DB-C5CE3E5B5455Q38137415-F4404D0A-85CA-4220-9B19-E5220E74762DQ38186633-796C0552-7285-4F31-A4AC-0F1E0C72EEDCQ38464030-86BD83C6-116F-4EDA-9904-8B1F7D34BDCEQ38527834-EDBBCA7E-FB38-4674-BDF7-69FF7701F91CQ40295849-9EE6C6FF-12BC-421D-9726-4A2592E79E7CQ41627673-821DBFF6-3BC6-4598-ADA9-658965A7D4A3Q43013693-8BC084DB-4D81-4822-B402-1A85C986B724Q43225777-CA884F88-E3F7-454A-80BA-9AD65F4B8D2FQ43231652-E1F901D3-1113-4D0D-A002-2C3E4B7D9D3AQ44064473-AAA035E7-1B55-4BFF-9C51-A74618A4E0D9Q44347925-5BA62B57-21EF-4819-B362-B41D2B36B680Q44387347-38B37F50-F4E8-4828-9EC2-8A2D3336975BQ45937479-71F9AF40-A036-42D8-95C2-0F8FE92EEE88Q46542223-FF0E898E-FEE6-4A15-8180-BDFA5FA94BA4Q46921303-15173B8E-CCF4-474F-8FF3-9DFE9433FFF7Q46965410-291855F9-1DF7-4532-B230-12E19BEBB3FF
P2860
The pathophysiology of aldosterone in the cardiovascular system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The pathophysiology of aldosterone in the cardiovascular system.
@ast
The pathophysiology of aldosterone in the cardiovascular system.
@en
The pathophysiology of aldosterone in the cardiovascular system.
@nl
type
label
The pathophysiology of aldosterone in the cardiovascular system.
@ast
The pathophysiology of aldosterone in the cardiovascular system.
@en
The pathophysiology of aldosterone in the cardiovascular system.
@nl
prefLabel
The pathophysiology of aldosterone in the cardiovascular system.
@ast
The pathophysiology of aldosterone in the cardiovascular system.
@en
The pathophysiology of aldosterone in the cardiovascular system.
@nl
P2860
P1476
The pathophysiology of aldosterone in the cardiovascular system.
@en
P2093
John W Funder
Ricardo Rocha
P2860
P304
P356
10.1111/J.1749-6632.2002.TB04415.X
P407
P577
2002-09-01T00:00:00Z